Physicochemical characterization of drug nanocarriers
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmaceutical design has enabled important advances in the prevention, treatment, and diagnosis of diseases. The use of nanotechnology to optimize the delivery of drugs and diagnostic molecules is increasingly receiving attention due to the enhanced efficiency provided by these systems. Understanding the structures of nanocarriers is crucial in elucidating their physical and chemical properties, which greatly influence their behavior in the body at both the molecular and systemic levels. This review was conducted to describe the principles and characteristics of techniques commonly used to elucidate the structures of nanocarriers, with consideration of their size, morphology, surface charge, porosity, crystalline arrangement, and phase. These techniques include X-ray diffraction, small-angle X-ray scattering, dynamic light scattering, zeta potential, polarized light microscopy, transmission electron microscopy, scanning electron microcopy, and porosimetry. Moreover, we describe some of the commonly used nanocarriers (liquid crystals, metal-organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, and micelles) and the main aspects of their structures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








![Figure 9 SAXS curves of the systems developed by Negrini et al,52 showing the reversibility of the mesophase following pH changes (pH 7 [lower curve] → pH 2 [middle curve] → pH 7 [upper curve]). Adapted with permission, from: Negrini R, Mezzenga R, pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 27(9), 2011, 5296–5303. Copyright 2017 American Chemical Society.52](https://figures.cochat.ai/paper-figures/096693895aa54288922b19e5981ebb0f/physicochemical-characterization-of-drug-nanocarriers-figure-9.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“60 Finally, third-generation liposomes have been developed with targeting molecules (antibodies and peptides) on their surfaces in order to provide receptor recognition and active targeting of the drug.”
Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrie, C., Baati, T., Eubank, J. F., Heurtaux, D., Clayette, P., Kreuz, C., et al. (2010) · Nature Materials · doi:10.1038/nmat2608 · Cited by 4,260 · cited 1×
“104 Compared with conventional porous materials, advantages of NMOFs include the ability to incorporate large amounts of drugs as well as their adjustable composition and structure.”
Transmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963 · cited 4×
“This is identical, in principle, to the more familiar medical computerized axial tomography (CAT) scans using X-rays.”
InfluentialDrug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848 · cited 1×
“87–89 More recently, discoveries based on inorganic nano-particles, such as mesoporous silica nanoparticles (MSNs), have opened up exciting new possibilities in this area.”
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 1×
“4,65,67 Table 5 lists SLN formulations, the drugs or active ingredients used, and structural details obtained from DLS, zeta potential, and TEM/cryo-TEM analyses.”
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651 · cited 1×
“Introduction Recent years have seen increasing research interest in the development of new drug delivery systems that are based on nanoparticles with dimensions ranging from 1 to 1,000 nm.(1) Compared to conventional drug delivery systems, the use of nanoparticles for drug delivery offers advantages, including high st…”
BackgroundSolid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150 · cited 2×
“4,65,67 Table 5 lists SLN formulations, the drugs or active ingredients used, and structural details obtained from DLS, zeta potential, and TEM/cryo-TEM analyses.”
Metal–organic frameworks: a new class of porous materials
Rowsell, J. L. C., & Yaghi, O. M. (2004) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2004.03.034 · Cited by 2,963
Mesoporous Materials for Drug Delivery
Vallet‐Regí, M., Balas, F., & Arcos, D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604488 · Cited by 2,507 · cited 3×
“85 The pore diameter can typically be altered in the range from 2 to 50 nm by changing the components of these materials, enabling the production of various mesoporous materials that are able to host small drug molecules or macromolecules.”
Influential
Cited by
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Understanding ligand-protected noble metal nanoclusters at work
Matus, M. F., & Häkkinen, H. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00537-1 · Cited by 356
Qi, J., Hu, X., Dong, X., Lu, Y., Lu, H., Zhao, W., & Wu, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.009 · Cited by 292
Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections
Wang, D.-Y., van der Mei, H. C., Ren, Y., Busscher, H. J., & Shi, L. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00872 · Cited by 208
“Liposome suspensions are considered to be unstable when their zeta potential is between −30 and +30mV (Manaia et al., 2017).”
BackgroundAdvances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Makowski, M., Silva, Í. C., do Amaral, C. P., Gonçalves, S., & Santos, N. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110588 · Cited by 162
“Different techniques are available, suitable for the peculiarities of each material [28].”
MethodSamrot, A. V., Sean, T. C., Kudaiyappan, T., Bisyarah, U., Mirarmandi, A., Faradjeva, E., Abubakar, A., Ali, H. H., Angalene, J. L. A., & Kumar, S. S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.104 · Cited by 133
Nanomedicines - Tiny particles and big challenges
Marques, M. R. C., Choo, Q., Ashtikar, M., Rocha, T. C., Bremer‐Hoffmann, S., & Wacker, M. G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.003 · Cited by 115
Advances in lyotropic liquid crystal systems for skin drug delivery
Silvestrini, A. V. P., Caron, A. L., Viegas, J. S. R., Praça, F. S. G., & Bentley, M. V. L. B. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1819979 · Cited by 111
Green synthesis of CuO nanoparticles for biological applications
Murugan, B., Rahman, M. Z., Fatimah, I., Lett, J. A., Annaraj, J., Kaus, N. H. M., Al-Anber, M. A., & Sagadevan, S. (2023) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2023.111088 · Cited by 103
Polymers and Polymer Nanocomposites for Cancer Therapy
Feldman, D. (2019) · Applied Sciences · doi:10.3390/app9183899 · Cited by 98
“Liposomes can be prepared through reverse-phase evaporation, the injection of phospholipids dissolved in an organic phase into a drug-containing aqueous phase, detergent dialysis, microfluidic hydrodynamic focus, supercritical reverse-phase evaporation, electroformation, microfluid liposome formation, and thin lipid f…”
MethodMultifunctional lipid-based nanoparticles for wound healing and antibacterial applications: A review
Motsoene, F., Abrahamse, H., & Kumar, S. S. D. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.103002 · Cited by 95
Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopy
Negwer, I., Best, A., Schinnerer, M., Schäfer, O., Capeloa, L., Wagner, M., Schmidt, M., Mailänder, V., Helm, M., Barz, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07755-0 · Cited by 81
Current state of nanomedicine drug products: An industry perspective
Clogston, J. D., Foss, W. R., Harris, D., Oberoi, H. S., Pan, J., Pu, E., Guzmán, E. A. T., Walter, K., Brown, S., & Soo, P. L. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.09.005 · Cited by 86
Lipidic lyotropic liquid crystals: Insights on biomedical applications
Blanco-Fernández, G., Blanco‐Fernandez, B., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102867 · Cited by 70
Muniz, B. V., Baratelli, D., Santos, S. D. C., Serpe, L., da Silva, C. B., Guilherme, V. A., Ribeiro, L. N. D. M., Cereda, C. M. S., de Paula, E., Volpato, M. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36382-4 · Cited by 67
Deshmukh, R. (2023) · Materials Today Communications · doi:10.1016/j.mtcomm.2023.105877 · Cited by 80
Petrović, S., & Barbinta-Patrascu, M. E. (2023) · Materials · doi:10.3390/ma16247550 · Cited by 67
“To overcome these limitations, the use of additional characterization methods such as nuclear magnetic resonance spectroscopy, infrared spectroscopy with Fourier transform [307], and microscopic analysis [308], is advisable.”
MethodRecent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems
Leu, J. S. L., Teoh, J. J. X., Ling, A. L. Q., Chong, J., Loo, Y. S., Azmi, I. D. M., Zahid, N. I., Bose, R. J., & Madheswaran, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051421 · Cited by 66
“These techniques can be used to determine the size, stability, shape, morphology, and dispersion state of nanometric systems [59,60].”
BackgroundMethodGrowth Inhibition of Gram-Positive and Gram-Negative Bacteria by Zinc Oxide Hedgehog Particles
Rutherford, D., Jíra, J., Kolářová, K., Matolı́nová, I., Míčová, J., Remes, Z., & Rezek, B. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s300428 · Cited by 57
Almatroudi, A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121602 · Cited by 64
“Normally, dynamic light scattering (DLS) and transmission electron microscopy (TEM) are employed together to achieve precise particle dimensions [94,95].”
A short review on the applicability and use of cubosomes as nanocarriers
Palma, A. S., Casadei, B. R., Lotierzo, M. C. G., de Castro, R. D., & Barbosa, L. R. S. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01089-y · Cited by 60
“In addition to the visual information about cubosomes, the detailed micrograph analysis also reveals information about each nanoparticle’s characteristic individuality (Manaia et al., 2017).”
BackgroundMethodTripathi, P. K., Gupta, S., Rai, S., Shrivatava, A., Tripathi, S., Singh, S., Khopade, A. J., & Kesharwani, P. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1724132 · Cited by 48
“A photo microgram of the formulation was taken [25].”
MethodPhysicochemical properties, pharmacokinetics, toxicology and application of nanocarriers
Cai, X., Jin, M. F., Yao, L., He, B., Ahmed, S., Safdar, W., Ahmad, I., Cheng, D., Lei, Z., & Sun, T. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb02001g · Cited by 53
Ornelas-Hernández, L. F., Garduno‐Robles, A., & Zepeda‐Moreno, A. (2022) · Nanoscale Research Letters · doi:10.1186/s11671-022-03691-7 · Cited by 50
Charlie‐Silva, I., Fraceto, L. F., & de Melo, N. F. S. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1505739 · Cited by 44
“The cholesterol is used to enhance bilayer fluidity [33].”
BackgroundMethodde Oliveira, J. F. A., Scheffer, F. R., Landis, R. F., Neto, É. T., Rotello, V. M., & Cardoso, M. B. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12351 · Cited by 45
Krajišnik, D. R., Uskoković‐Marković, S., & Daković, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910377 · Cited by 42
“In addition to the physicochemical characterization [144], the evaluation of the biological efficacy and technological properties to verify the safety of these functional materials requires carrying out appropriate toxicological studies.”
BackgroundSolid Lipid Nanoparticles (SLN)
Hernández-Esquivel, R. A., Navarro‐Tovar, G., Zárate-Hernández, E., & Aguirre-Bañuelos, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102536 · Cited by 44
Tetyczka, C., Hodžić, A., Kriechbaum, M., Juraić, K., Spirk, C., Hartl, S., Pritz, E., Leitinger, G., & Roblegg, E. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.03.017 · Cited by 40
“It is utilized to identify the crystalline structure, the average nanocrystal size and the degree of crystallinity [10,18,19].”
Heil, C. M., Patil, A., Dhinojwala, A., & Jayaraman, A. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00382 · Cited by 41
Muneer, S., Wang, X., Rintoul, L., Ayoko, G. A., Islam, N., & Izake, E. L. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119684 · Cited by 39
Shining Light on Polymeric Drug Nanocarriers with Fluorescence Correlation Spectroscopy
Schmitt, S., Nuhn, L., Barz, M., Butt, H., & Koynov, K. (2022) · Macromolecular Rapid Communications · doi:10.1002/marc.202100892 · Cited by 40
Tao, X., Tao, T., Wen, Y., Yi, J., He, L., Huang, Z., Nie, Y., Yao, X., Wang, Y., He, C., et al. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2769-x · Cited by 38
Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
Hayder, M. A., Abid, H. R., Sunderland, B., & Wang, S. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s182983 · Cited by 37
The clinical pharmacokinetics impact of medical nanometals on drug delivery system
Alalaiwe, A. S. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.004 · Cited by 39
Nanoparticle Brain Delivery: A Guide to Verification Methods
Yokel, R. A. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0169 · Cited by 42
“Electron microscopy, typically TEM, is not only the best technique to characterize prepared NPs, it is also amenable to physicochemically identify and characterize NPs in samples obtained from biological environments [56– 58] .”
BackgroundResultElnaggar, Y. S. R., Elwakil, B. H., Elshewemi, S. S., El‐Naggar, M. Y., Bekhit, A. A., & Olama, Z. A. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0467 · Cited by 36
Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles
Ahmadi, A., Sokunbi, M. O., Patel, T., Chang, M., Ahmad, Z., & Singh, N. (2022) · Nanomaterials · doi:10.3390/nano12122016 · Cited by 36
Li, C., Gou, X., & Gao, H. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0329 · Cited by 35
Polymeric Micro/Nanocarriers and Motors for Cargo Transport and Phototriggered Delivery
Mena‐Giraldo, P., & Orozco, J. (2021) · Polymers · doi:10.3390/polym13223920 · Cited by 34
Niosomes as Vesicular Nanocarriers in Cosmetics: Characterisation, Development and Efficacy
Lens, M. B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030287 · Cited by 36
“As an indirect measure of surface charge, the zeta potential predicts the stability of a nanoformulation [14].”
Nano Spray-Dried Drugs for Oral Administration: A Review
Öztürk, A. A., & Arpagaus, C. (2021) · Assay and Drug Development Technologies · doi:10.1089/adt.2021.053 · Cited by 36
“210 In a study, anti-inflammatory aceclofenac-loaded Eudragit RS 100 and ethyl cellulose microparticles (MPs)/NPs were prepared by nano spray drying.”
Zambom, C. R., da Fonseca, F. H., Crusca, E., da Silva, P. B., Pavan, F. R., Chorilli, M., & Garrido, S. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01667 · Cited by 33
Mechanism of structural colors in binary mixtures of nanoparticle-based supraballs
Heil, C. M., Patil, A., Vanthournout, B., Singla, S., Bleuel, M., Song, J.-J., Hu, Z., Gianneschi, N. C., Shawkey, M. D., Sinha, S. K., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf2859 · Cited by 31
In Vitro and In Vivo Anti-Aging Effect of Coffee Berry Nanoliposomes
Saewan, N., Jimtaisong, A., Panyachariwat, N., & Chaiwut, P. (2023) · Molecules · doi:10.3390/molecules28196830 · Cited by 31
“Nor-mally, zeta potentials greater than +30 mV or less than − 30 mV are regarded as stable [32 The Normally, zeta potentials greater than +30 mV or less than −30 mV are regarded as stable [32].”
Silva, R. O., da Costa, B. L., da Silva, F. R., da Silva, C. N., de Paiva, M. R. B., Dourado, L. F. N., Malachias, Â., Araújo, A. A. D. S., Nunes, P. S., & Silva‐Cunha, A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118466 · Cited by 34
Albumin-based Nanoparticles as Promising Drug Delivery Systems for Cancer Treatment
Esim, O., & Hasçiçek, C. (2020) · Current Pharmaceutical Analysis · doi:10.2174/1573412916999200421142008 · Cited by 32
Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications
Zielińska, A., Szalata, M., Gorczyński, A., Karczewski, J., Eder, P., Severino, P. B., Cabeda, J. M., Souto, E. B., & Słomski, R. (2021) · Cancers · doi:10.3390/cancers13081896 · Cited by 32
“Finally, it shows an exponential decay related to the ZP [41].”
BackgroundMethodInfluentialMultiple Natural Polymers in Drug and Gene Delivery Systems
Jiang, Z., Song, Z., Cao, C., Yan, M., Liu, Z., Cheng, X., Wang, H., Wang, Q., Liu, H., & Chen, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230316094540 · Cited by 30
Characterization Methods for Nanoparticle–Skin Interactions: An Overview
Dzyhovskyi, V., Romani, A., Pula, W., Bondi, A., Ferrara, F., Melloni, E., Gonelli, A., Pozza, E., Voltan, R., Sguizzato, M., et al. (2024) · Life · doi:10.3390/life14050599 · Cited by 33
“DLS finds extensive applications in various fields, including the evaluation of the formulation stability over time and temperature variations, identification of aggregates in different formulations, and a rapid determination of particle size in monodisperse samples [88].”
BackgroundMethodInfluentialParadigm of lyotropic liquid crystals in tissue regeneration
Shah, S., Joga, R., Kolipaka, T., Sabanis, C. D., Khairnar, P., Simran, Phatale, V., Pandey, G., Srivastava, S., & Kumar, S. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122633 · Cited by 28
Schmitt, S., Huppertsberg, A., Klefenz, A., Kaps, L., Mailänder, V., Schuppan, D., Butt, H., Nuhn, L., & Koynov, K. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.1c01407 · Cited by 28
Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections
Mosallam, F. M., Bendary, M. M., Elshimy, R. M., & El-Batal, A. I. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03745-7 · Cited by 25
Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy
Jin, X., Yang, Q., & Cai, N. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s167529 · Cited by 24
“Generally, they are considered a safe and biocompatible long-circulating drug delivery system when covered with a hydrophilic polymer shell.(37) A number of polymeric micelles have been regarded as passive targeting agents and tested in clinical trials.”
Nanoemulsions Loaded with Amphotericin B: Development, Characterization and Leishmanicidal Activity
Araújo, G. M. F., Araújo, G. M. F., Barros, A. R. A., Barros, A. R. A., Oshiro, J. A., Oshiro, J. A., Soares, L. F., Soares, L. F., da Rocha, L. G., da Rocha, L. G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190705202030 · Cited by 24
Alves, A. D. C. S., Bruinsmann, F. A., Guterres, S. S., & Pohlmann, A. R. (2021) · Molecules · doi:10.3390/molecules26144127 · Cited by 24
“Absolute values of ζ potential higher than 30 mV predict better stability of colloidal dispersions, when the mechanism of stability is based on the electrostatic repulsion [84,85].”
BackgroundImproved oral bioavailability of magnolol by using a binary mixed micelle system
Ding, P., Shen, H., Wang, J., & Ju, J. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1468339 · Cited by 24
“The morphology of MO-M was observed by transmission electron microscopy (TEM, JEM-200CX, JEOL, Japan) [35].”
MethodManna, K., Roy, A., Dey, S., Ghosh, S., Pradhan, P., & Pal, S. (2024) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2024.2335277 · Cited by 25
“…SAXS studies, which provide a thorough description of the size, shape, and interior architecture of the micelles on a length scale of 1–100 nm. [116,117] Polymeric micelles can take on various shapes, including nanoscale spheroids, ellipsoidal objects, rod-like or disk-like, contingent on the…”
BackgroundDifferent instrumental approaches to understand the chitosan coated niosomes/mucin interaction
Rinaldi, F., Hanieh, P. N., Imbriano, A., Passeri, D., Favero, E. D., Rossi, M., Marianecci, C., Panfilis, S. D., & Carafa, M. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101339 · Cited by 23
Improvement of Transfection with PepFects Using Organic and Inorganic Materials
Dowaidar, M., Abdelhamid, H. N., & Langel, Ü. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1752-6_35 · Cited by 23
Drost, M., Diamanti, E., Fuhrmann, K., Goes, A., Shams, A., Haupenthal, J., Koch, M., Hirsch, A. K. H., & Fuhrmann, G. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010004 · Cited by 21
“8 mV (Figure 2b), which is regarded as disadvantageous in terms of fusion or aggregation [39].”
BackgroundRen, W., Nan, F., Li, S., Yang, S., Ge, J., & Zhao, Z. (2020) · ChemMedChem · doi:10.1002/cmdc.202000420 · Cited by 20
Molecular interactions between Pluronic F127 and the peptide tritrpticin in aqueous solution
Salay, L. C., Prazeres, E. A., Marín, N., Lemos, M., Piccoli, J. P., Sanches, P. R. D. S., Cilli, E. M., Santos, R. S., & Feitosa, E. (2018) · Colloid & Polymer Science · doi:10.1007/s00396-018-4304-0 · Cited by 20
“There are many factors that affect the zeta potential, such as particle and electrolyte type and concentration, and additives in general [47].”
BackgroundArslanov, V. V., Ermakova, E. V., Krylov, D. I., & Popova, O. O. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.02.110 · Cited by 19
Surface receptor-targeted protein-based nanocarriers for drug delivery: advances in cancer therapy
Theivendren, P., Pavadai, P., Veerachamy, S., Palanisamy, P., & Kunjiappan, S. (2025) · Nanotechnology · doi:10.1088/1361-6528/adad7a · Cited by 22
“Different physicochemical properties of nanocarriers, such as size, surface charge and drug encapsulation efficiency, are crucial for their function in the delivery of drugs [129, 130].”
Chaupard, M., de Frutos, M., & Gref, R. (2021) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202100022 · Cited by 19
Nanoformulations - Insights Towards Characterization Techniques
Vijayaraghavalu, S., Krishnaswami, V., Sugumaran, A., Perumal, V., Manavalan, M., Kondeti, D. P., Basha, S. K., Ahmed, M. A., & Kumar, M. (2022) · Current Drug Targets · doi:10.2174/1389450123666220822094248 · Cited by 17
Santos, P. C. E., Granero, F. O., Bronzel, J. L., Pavarini, R., Pavarini, G. M. P., Chorilli, M., Zambom, C. R., Silva, L. P., & da Silva, R. M. G. (2022) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2022.102511 · Cited by 17
Adeleke, O. A., Hayeshi, R. K., & Davids, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030286 · Cited by 17
“Researchers have shown that TEM imaging is an effective and powerful tool for characterizing the morphology of nano- and micro-structured biomaterials and drug carriers as it uses more powerful beams to produce higher resolution images with more details and information [30,31].”
BackgroundAlonso, M., Fernández-Carballido, A. M., Quispe-Chauca, P., Lozza, I., Martín‐Sabroso, C., & Fraguas‐Sánchez, A. I. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.09.022 · Cited by 17
Vanti, G., Tomou, E., Stojković, D. S., Ćirić, A., Bilia, A. R., & Skaltsa, H. D. (2021) · Molecules · doi:10.3390/molecules26082124 · Cited by 17
“Average hydrodynamic diameter (nm), polydispersity index (PdI) and ζ‐potential (mV) of the developed nanovesicles were measured by Dynamic and Electrophoretic Light Scattering, DLS/ELS (Zetasizer Nanoseries ZS90) by Malvern instrument (Worces‐ tershire, UK), at 25 °C, with a scattering angle of 90 °C [38,39].”
MethodLimonene encapsulated alginate/collagen as antibiofilm drug against Acinetobacter baumannii
Valookolaei, F.-S. G. T., Sazegar, H., & Rouhi, L. (2024) · BMC Biotechnology · doi:10.1186/s12896-024-00888-9 · Cited by 17
“Due to their tiny size, nanocarriers may enhance the stability of compounds and have the capacity to transport substantial quantities of drugs dependent on their physicochemical qualities [18].”
BackgroundFundamentals of protein affinity chromatography: How to prepare and properly use an affinity matrix
Bílková, Z., Shabani, E., Moravek, O., Korecká, L., Slováková, M., & Jankovičová, B. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.466061 · Cited by 17
Oliver, R. C., Rolband, L. A., Hutchinson-Lundy, A. M., Afonin, K. A., & Krueger, J. K. (2019) · Nanomaterials · doi:10.3390/nano9050681 · Cited by 16
“Static Light Scattering (SLS)/Dynamic Light Scattering (DLS)/ Zeta Potential [28] Hydrodynamic particle size, size distributions, surface charge Sample volumes are small (μL) Particle size across a broad range (~0.”
BackgroundMethodInfluentialDevelopment of nano structured graphene oxide incorporated dexamethasone with enhanced dissolution
Islam, M. S., & Mitra, S. (2022) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2022.100599 · Cited by 15
Nguyen, D. C. T., Dowling, J., Ryan, R., McLoughlin, P., & Fitzhenry, L. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121793 · Cited by 16
Chen, Y., Xu, S., Ren, S., Zhang, J., Xu, J., Song, Y., Peng, J., Zhang, S., Du, Q., & Chen, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.017 · Cited by 14
“However, the lower potential may tend to form unstable conditions such as aggregation, coagulation, and flocculation [41,42].”
Heil, C. M., & Jayaraman, A. (2021) · ACS Materials Au · doi:10.1021/acsmaterialsau.1c00015 · Cited by 14
Progress in research and development of temozolomide brain-targeted preparations: a review
Yang, J., Xu, Y., Fu, Z., Chen, J., Fan, W., & Wu, X. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2119243 · Cited by 15
“Passive targeting makes use of the EPR effect and permeation by taking advantages of the surface properties of NPs to accumulate the drug at the tumour site [57, 110].”
BackgroundRani, M., Parekh, K., Mehta, T. A., & Omri, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105250 · Cited by 22
Effect of Freeze-Thaw Cycles Method to Transfersome Characteristics for Growth Protein Encapsulation
Khayrani, A. C., Fahmi, M. A. M. M., Nurhayati, R. W., Manas, N. H. A., & Suhaeri, M. (2024) · International Journal of Technology · doi:10.14716/ijtech.v15i2.6670 · Cited by 14
Le‐Deygen, I. M., Скуредина, А. А., & Kudryashova, E. V. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162020040123 · Cited by 13
Jung, B. T., Lim, M., Jung, K., Li, M., Dong, H., Dube, N., & Xu, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.037 · Cited by 13
Akbar, M. J., Wali, A. F., Talath, S., Aljasser, A., Aldurdunji, M. M., Alqahtani, F., Sridhar, S. B., Begum, M. Y., & Hani, U. (2025) · Scientific Reports · doi:10.1038/s41598-025-92888-8 · Cited by 12
Gonçalves, S., Martins, I. C., & Santos, N. C. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1819 · Cited by 12
Design, optimization & characterization of niosomal & polymeric nanoparticles
Tariq, F., Zaman, M., Waqar, M. A., Saeed, M. A., & Sarfraz, R. M. (2023) · International Journal of Polymeric Materials · doi:10.1080/00914037.2023.2277235 · Cited by 16
“A critical aspect of nanoparticle development as drug delivery vehicles is the physical and chemical characterization of the particles [105–107] .”
Marzec, M., Souto, E. B., & Nowak, I. (2021) · Molecules · doi:10.3390/molecules26113161 · Cited by 13
“The choice of the method of the synthesis of lipid nanoparticles is determined by the nature of the active substance to be incorporated, the target structure and size of the carrier, and the expected release profile of the encapsulated active ingredient, which is closely related to the intended application site [1,2].”
Natural biodegradable and polymeric nanoparticles for the delivery of noscapine for cancer treatment
Yadav, K., Yadav, D., Kumar, S., Kishore, N., El‐Sherbiny, M., Al‐Serwi, R. H., Othman, G., Sendy, J. S., & Mohamed, J. M. M. (2022) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-03334-y · Cited by 12
“Most notably, altering the physicochemical features of the polymer (molecular weight, polydispersity index, hydrophobicity, and crystallinity) allows for adjustment of the physicochemical properties and drug release properties of nanoparticles [5].”
Physicochemical Characterization of Bioactive Compounds in Nanocarriers
Barros, R. M., de Oliveira, M. S., Costa, K. M. N., Sato, M. R., Santos, K. L. M., Damasceno, B. P. G. D. L., Cuberes, M. T., & Oshiro, J. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200310144533 · Cited by 12
Colon-targeted oral nanoliposomes loaded with psoralen alleviate DSS-induced ulcerative colitis
Su, L., Song, G., Zhou, T., Tian, H., Xin, H., Zou, X., Xu, Y., Jin, X., Gui, S., & Lu, X. (2024) · Biomaterials Science · doi:10.1039/d4bm00321g · Cited by 11
Nanomedicines and Nanodrug Delivery Systems: Trends and Perspectives
Das, S., Das, M. K., Deka, T., Singha, L. R., & Das, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6255-6_6 · Cited by 13
Lipid Constituents of Diatoms (Halamphora) as Components for Production of Lipid Nanoparticles
Marzec, M., Dąbek, P., Witkowski, A., Monedeiro, F., Pomastowski, P., Buszewski, B., & Nowak, I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061171 · Cited by 13
“The addition of a liquid lipid to the lipid matrix provided the possibility to increase the amount of incorporated active ingredient and improve the physical stability of the lipid nanoparticle dispersion [18,19].”
BackgroundDrug Encapsulation: Review of Niosomes for Promoting Antimicrobial Activity
do Nascimento, T., Garófalo, D. D. A., Monteiro, M. S. D. S. D. B., Santos‐Oliveira, R., Matos, A. P. D. S., & Ricci‐Júnior, E. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05637-7 · Cited by 12
Fonseca‐Santos, B., Araujo, G. A., Ferreira, P. S., Victorelli, F. D., Pironi, A. M., Araújo, V. H. S., Carvalho, S. G., & Chorilli, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020366 · Cited by 11
“Anisotropy is characteristically used for classification of lyotropic LCs [53], while lamellar mesophases display Maltese’s crosses [44,47] and hexagonal mesophases present as stretch marks under PLM [46].”
BackgroundMethodNanotechnology in Oral Cavity Carcinoma: Recent Trends and Treatment Opportunities
Felice, F. D., Cavallini, C., Barlattani, A., Tombolini, M., Brugnoletti, O., Tombolini, V., & Polimeni, A. (2019) · Nanomaterials · doi:10.3390/nano9111546 · Cited by 11
Bioadhesive liquid crystal systems for octyl methoxycinnamate skin delivery
do Prado, A. H., Duarte, J. L., Filippo, L. D. D., Victorelli, F. D., Fantini, M. C. D. A., Peccinini, R. G., & Chorilli, M. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.117450 · Cited by 13
Nodari, C. H., Quadros, N. D. D., Chiarentin, R., da Silva, F. P., Morisso, F. D. P., Charão, M. F., Fleck, J. D., de Mattos, C. B., Betti, A. H., & Verza, S. G. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00412-w · Cited by 10
“The liposome structure is constituted of vesicular phospholipid membranes that allow the incorporation of hydrophilic drugs inside the cavity, and hydrophobic drugs in the phospholipid bilayer [16].”
BackgroundInfluentialNanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
Ranasinghe, R., Mathai, M. L., Alshawsh, M. A., & Zulli, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28171 · Cited by 10
Jiménez-Jiménez, S., Cordero-Sánchez, S., Mejía-Hernández, J.-G., Quintanar‐Guerrero, D., Melgoza-Contreras, L. M., & Villalobos-García, R. (2025) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902025e24249 · Cited by 11
Porrang, S., Baran, G., & Mustafaoğlu, N. (2025) · RSC Advances · doi:10.1039/d5ra06132f · Cited by 10
“6,50 The LE of RMSN and HMSN was determined to be 70 ± 1.05 and 68 ± 3.9%, respectively.”
Influential
Metadata
- Authors
- Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L.
- Affiliations
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Chiavacci, Leila
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-07
- Volume
- Volume 12
- Pages
- 4991-5011
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC5516877
- OpenAlex
- W2734423857
- Cited by
- 207
- References
- 114
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 25 · 2023: 30 · 2022: 29 · 2021: 21 · 2020: 22 · 2019: 17 · 2018: 14
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- UNESP Institutional Repository (São Paulo State University) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade Estadual Paulista
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- drug nanocarriers, physicochemical characterization, surface charge, porosity, liquid crystals, metal-organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, micelles, drug delivery
- MeSH terms
- Dynamic Light Scattering, Drug Carriers, Liposomes, Micelles, Microscopy, Silicon Dioxide, X-Ray Diffraction, Nanotechnology, Microscopy, Electron, Transmission, Nanostructures, Liquid Crystals, Nanoparticles, Scattering, Small Angle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.